Sorrento Therapeutics, Inc.:企業のM&A・事業提携・投資動向

【英語タイトル】Sorrento Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

MarketLineが出版した調査資料(DATA904C2125)・商品コード:DATA904C2125
・発行会社(調査会社):MarketLine
・発行日:2018年7月
・ページ数:89
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Sorrento Therapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Sorrento Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Sorrento Therapeutics, Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Sorrento Therapeutics, Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Sorrento Therapeutics, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Sorrento Therapeutics, Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Sorrento Therapeutics, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Sorrento Therapeutics, Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Sorrento Therapeutics, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 15
Partnership – Overview 15
Partnership – Deal reports 16
CAPITAL RAISING 52
Capital Raising – Overview 52
Capital Raising – Deal reports 53
DIVESTMENTS 62
Divestments – Overview 62
Divestments – Deal reports 63
PRIVATE EQUITY & OWNERSHIP 65
Private Equity and Ownership – Overview 65
Private Equity and Ownership – Deal reports 66
APPENDIX 79
Contact Us 79
About MarketLine Financial Deals Database 79
Deal Definition and Methodology 81
About MarketLine 88

List of Tables
Table 1: Sorrento Therapeutics partnership volume and value trend (2014-YTD2018)
Table 2: Sorrento Therapeutics partnership trend by key deal type (2014-YTD2018)
Table 3: Sorrento Therapeutics capital raising volume and value trend (2014-YTD2018)
Table 4: Sorrento Therapeutics capital raising by deal type (2014-YTD2018)
Table 5: Sorrento Therapeutics divestments volume and value trend (2014-YTD2018)
Table 6: Sorrento Therapeutics divestments activity by geography (2014-YTD2018)
Table 7: Sorrento Therapeutics private equity and ownership volume and value trend (2014-YTD2018)
Table 8: Sorrento Therapeutics private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Sorrento Therapeutics partnership volume and value trend (2014-YTD2018)
Figure 2: Sorrento Therapeutics partnership trend by key deal type (2014-YTD2018)
Figure 3: Sorrento Therapeutics capital raising volume and value trend (2014-YTD2018)
Figure 4: Sorrento Therapeutics capital raising by deal type (2014-YTD2018)
Figure 5: Sorrento Therapeutics divestments volume and value trend (2014-YTD2018)
Figure 6: Sorrento Therapeutics divestments by geography (2014-YTD2018)
Figure 7: Sorrento Therapeutics private equity and ownership volume and value trend (2014-YTD2018)
Figure 8: Sorrento Therapeutics private equity and ownership by deal type (2014-YTD2018)

★調査レポート[Sorrento Therapeutics, Inc.:企業のM&A・事業提携・投資動向] (コード:DATA904C2125)販売に関する免責事項を必ずご確認ください。
★調査レポート[Sorrento Therapeutics, Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆